Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Sibutramine

Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients

Abbott · Phase 3 · Status n/r · Enrollment 60

NCT00941382

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Sibutramin-Metforminn/rn/rn/rn/r
Sibutraminen/rn/rn/rn/r
Metforminn/rn/rn/rn/r

Not shown

  • Sibutramin-Metformin: endpoint not reported
  • Sibutramine: endpoint not reported
  • Metformin: endpoint not reported